Press Center

Russian pharmaceutical manufacturers are increasingly looking toward the GCC and MENA regions. But "entering" and "establishing a foothold" are challenges of entirely different magnitudes.

The two key markets in the region — the UAE and Saudi Arabia — despite their undeniable appeal, require fundamentally different approaches.

Together with the Pharvestnik Magazine, Julia Kuzmenko, Counsel and Head of Regulatory Practice at Lidings, examined the nuances of the regulatory architecture in these two jurisdictions.

The study presents a comparative legal analysis of the regulation of artificial intelligence ("AI"), with a focus on judicial practice in three post-Soviet states — Russia, Belarus, and Kazakhstan.

• pdf, 379.23 kb

On July 8, 2026, the State Duma adopted in the third reading draft law No. 951518-8 on amendments to Article 12 of the Federal Law "On Personal Data" and certain legislative acts of the Russian Federation.

The approach to forming the list of foreign countries that ensure adequate protection of the rights of personal data subjects ("PD") has been changed.

Lidings’ Partner Stepan Guzey will visit Muscat, Sultanate of Oman, for a series of meetings with representatives of leading local law firms to discuss the prospects for cross-border cooperation.

The Lidings team, led by Managing Partner Boris Malakhov and including Senior Associate Vladislav Ryabov, Associate Ivan Vasiliev, and Junior Associate Alena Troitskaya, advised the client in the dispute concerning intellectual property and brand protection in the Russian Federation.

On April 23, Stepan Guzey, Partner at Lidings, took part in the podcast "What Contracts Keep Silent: Real Legal Risks of Logistics in the Middle East," organized by PARI Insurance Company.

India has long and firmly established itself as the ‘pharmacy of the world’, as the country produces a fifth of all generics and provides affordable medicines to millions of people across the globe. However, India is now transitioning from copying innovative molecules to creating them. Amid the restructuring of global supply chains and strategic rapprochement with Russia, India is becoming both a battleground for fierce patent wars and a unique laboratory for joint research. How can Russian pharmaceutical companies establish intellectual property protection in a jurisdiction where the balance between the interests of pharmaceutical giants and the affordability of medicines for the population is enshrined in law? Boris Malakhov and Natalya Thotahewage analyse the key features of patenting and the prospects for technological alliances between Moscow and Delhi.

On 2 February 2024, the Online Safety Act, No. 9 of 2024 (hereinafter referred to as the “OSA”) was officially published in Sri Lanka. The OSA is a significant and controversial element of information security regulation in Sri Lanka. It establishes provisions prohibiting the communication of prohibited statements online and aims to prevent the use of online accounts and inauthentic online accounts for prohibited purposes.

On January 16, 2026, as part of the Lidings Global – Indian Desk project, the expert webinar "Opportunities for Indian Medical Device Manufacturers in the Russian Market" took place. The event was organized by Lidings in cooperation with the Association of Indian Manufacturers of Medical Devices (AiMeD) and the LexCounsel Law Offices. The webinar was designed exclusively for AiMeD member companies, targeting senior management, specialists from manufacturing firms, and industry experts.

On October 22nd, an online discussion will take place, focusing on the operations of Russian businesses in the Middle East and North Africa (MENA) countries under sanctions pressure. The event is organized by the Legal Insight magazine and the Russian Export Center.